BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12609771)

  • 41. Pituitary adenylate cyclase-activating polypeptide stimulates steroidogenesis and adenosine 3',5'-monophosphate accumulation in cultured rat granulosa cells.
    Zhong Y; Kasson BG
    Endocrinology; 1994 Jul; 135(1):207-13. PubMed ID: 8013355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.
    Hannibal J; Ekblad E; Mulder H; Sundler F; Fahrenkrug J
    Cell Tissue Res; 1998 Jan; 291(1):65-79. PubMed ID: 9394044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression.
    Pavelock KA; Girard BM; Schutz KC; Braas KM; May V
    J Neurochem; 2007 Feb; 100(3):603-16. PubMed ID: 17181550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro.
    Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD
    Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in pituitary adenylate cyclase activating peptide and vasoactive intestinal peptide innervation of rat oxyntic mucosa during ulcer healing.
    Mei Q; Sundler F
    Neuropeptides; 1998 Dec; 32(6):527-35. PubMed ID: 9920450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
    Absood A; Chen D; Wang ZY; Håkanson R
    Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alfa 1 adrenergic potentiation of progesterone accumulation stimulated by vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) in cultured rat granulosa cells.
    Wasilewska-Dziubiñska E; Borowiec M; Chmielowska M; Woliñska-Witort E; Baranowska B
    Neuro Endocrinol Lett; 2002 Apr; 23(2):141-8. PubMed ID: 12011800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PACAP 1-38 as neurotransmitter in the porcine antrum.
    Tornøe K; Hannibal J; Georg B; Schmidt PT; Hilsted L; Fahrenkrug J; Holst JJ
    Regul Pept; 2001 Sep; 101(1-3):109-21. PubMed ID: 11495686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrical and mechanical effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in the rat colon involve different mechanisms.
    Plujà L; Fernández E; Jiménez M
    Eur J Pharmacol; 2000 Feb; 389(2-3):217-24. PubMed ID: 10688987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
    Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
    Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons.
    Mulder H; Uddman R; Moller K; Elsås T; Ekblad E; Alumets J; Sundler F
    Regul Pept; 1995 Sep; 59(1):121-8. PubMed ID: 12506422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
    Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction.
    Girard BM; May V; Bora SH; Fina F; Braas KM
    Regul Pept; 2002 Nov; 109(1-3):89-101. PubMed ID: 12409220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural characterization of PACAP receptors on rat liver plasma membranes.
    Nguyen TD; Heintz GG; Wolfe MS
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G811-8. PubMed ID: 8238511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.